Natco Pharma Ltd. Company Cash Flow Statement & Analysis

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Profit Before Tax	2,226	1,555.30	770.70	155.90	392.20
Net CashFlow-Operating Activity	1,662	1,196.40	784.40	57.70	183.50
Net Cash Used In Investing Activity	-1,443.90	-960.50	-436.60	-92.50	-3.20
NetCash Used in Fin. Activity	-212.40	-237.30	-346.80	35.60	-183.10
Net Inc/Dec In Cash And Equivlnt	5.70	-1.40	1	0.80	-2.80
Cash And Equivalnt Begin of Year	5.50	6.90	5.90	5.10	7.90
Cash And Equivalnt End Of Year	11.20	5.50	6.90	5.90	5.10

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article